Boehringer Ingelheim (BI) has selected three research proposals to fund as part of its 2017 Advancement in Equine Research Award program. Since 2011 BI has given more than $470,000 to advancing the knowledge of equine infectious disease.
Today marks the 10th time that Boehringer Ingelheim has received a perfect score on the Corporate Equality Index (CEI) and has been designated as a 2018 Best Place to Work for LGBTQ Equality.
Boehringer Ingelheim today announced it has been named to Science magazine’s annual list of “top employers” within the pharmaceutical and biotechnology industry for the 13th consecutive year. Boehringer Ingelheim was one of only 20 companies recognized.
Boehringer Ingelheim (BI) and EquiManagement magazine are pleased to announce this year’s Champions of the Cause Award winners, Darla Garon and Hannah Schlanger.
As part of a three-year commitment, Boehringer Ingelheim has become FEI Equine Health Partner and FEI Campus Partner.
Boehringer Ingelheim announced today that for the sixth consecutive year it has been named to Working Mother magazine’s annual 100 Best Companies list.
Travel can significantly increase the risk of a horse contracting an infectious disease.
As the days get shorter and opportunities for equine activities dwindle, the immunity provided by some vaccinations administered earlier in the year may also be diminishing.
Poor performance can stem from a variety of issues; however, there are a few things we know.
Boehringer Ingelheim once again invites public and private researchers studying equine infectious diseases to submit proposals for the 2017 Equine Research Awards.
Boehringer Ingelheim Animal Health (BIAH) is pleased to announce that Surpass (1% diclofenac sodium) is back on the market after a two-year absence.
Veterinary technicians and assistants play a critical role in horse health. To recognize their contributions, Boehringer Ingelheim (BI), EquiManagement magazine, and the American Association of Equine Veterinary Technicians and Assistants (AAEVT) are accepting nominations for the Champions of the Cause Award for the third year. The nomination period will run from April 17, 2017 to July 14, 2017.